ClinicalTrials.Veeva

Menu

Effect of Real-time Continuous Glucose Monitoring on Glucose Control and Outcomes of Critically Ill Patients

K

Kang Yan

Status

Unknown

Conditions

Hyperglycemia

Treatments

Other: Different methods of blood glucose monitoring between groups

Study type

Interventional

Funder types

Other

Identifiers

NCT01992965
CGM-ky0521

Details and patient eligibility

About

The purpose of the study is to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.

Full description

Real-time continuous glucose monitoring system has shown great accuracy and feasibility in critically ill patients. However, its impact on glucose control and outcomes has nearly unknown. Thus, Investigators designed this study to evaluate the effect of real-time continuous glucose monitoring system on glucose control and outcomes of critically ill patients.

Enrollment

144 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • More than 18 years old male or female;

    • Expected ICU stays longer than 72 hours;

      • Glucose level more than 8 mmol/L when enrolls in the ICU;

        • Patients or their legal surrogates have signed the informed consent.

Exclusion criteria

  • Pregnant or lactating women;

    • ICU stays less than 72 hours;

      • Usage of real-time continuous glucose monitoring system is considered as a contraindication.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

144 participants in 2 patient groups

Continuous Glucose Monitoring Group
Experimental group
Description:
Continuous Glucose Monitoring Group: Different methods of blood glucose monitoring between groups, and this group will use real-time continuous glucose monitoring system with alarm limits(high and low limit is 10 mmol/L and 8 mmil/L , respectively ) up to five days for glucose control, the target mean glucose level is between 8 and 10 mmol/L.
Treatment:
Other: Different methods of blood glucose monitoring between groups
Conventional Group
Active Comparator group
Description:
Conventional Group: Different methods of blood glucose monitoring between groups, and this group will use finger prick blood glucose measurements for glucose control with the same target mean glucose level of 8 -10 mmol/L. Patients also wear real-time continuous glucose monitoring system to collect glucose measurements. The values of real-time continuous glucose monitoring system are blinded to investigator and patients.
Treatment:
Other: Different methods of blood glucose monitoring between groups

Trial contacts and locations

1

Loading...

Central trial contact

Yan Kang, MD; Yan-yan Zuo, MM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems